{
    "hands_on_practices": [
        {
            "introduction": "A frequent challenge in pediatric practice is distinguishing benign, self-resolving reactive lymphadenopathy from bacterial infections that require antibiotics. This exercise  hones your ability to apply key clinical and laboratory criteria to make this distinction confidently. It emphasizes the importance of antibiotic stewardship and the critical skill of providing clear, comprehensive safety-net instructions to parents.",
            "id": "5114882",
            "problem": "A $9$-year-old child presents with $3$ days of mild upper respiratory infection (URI; upper respiratory infection) symptoms (rhinorrhea, mild sore throat), no odynophagia, no dysphagia, and normal energy and appetite. On examination, there are bilateral, mobile, non-tender submandibular lymph nodes measuring approximately $1$ cm each, with normal overlying skin, no fluctuance, and full, painless neck range of motion. The child is afebrile with a measured temperature of $36.8^\\circ\\text{C}$. A complete blood count (CBC; complete blood count) shows white blood cells $7.8\\times 10^9/\\text{L}$ without left shift, hemoglobin and platelets within age-appropriate reference ranges. C-reactive protein (CRP; C-reactive protein) is $5$ mg/L and erythrocyte sedimentation rate (ESR; erythrocyte sedimentation rate) is $12$ mm/hour. There is no trismus, drooling, or respiratory distress. Parents report the nodes were first noticed today.\n\nUsing the core definition that lymph nodes are immunologic filters where antigen presentation and lymphocyte proliferation occur, and the well-tested observation that viral URI commonly causes reactive cervical lymphadenopathy that is bilateral, small, mobile, and non-tender without systemic toxicity or elevated inflammatory markers, and that suppurative bacterial lymphadenitis more often presents as unilateral, tender nodes with overlying erythema, warmth, fever, and elevated inflammatory markers, select the management plan that most appropriately defers antibiotics while integrating antibiotic stewardship and provides robust safety-net instructions grounded in the natural history and potential complications of cervical lymphadenitis.\n\nWhich option is most appropriate?\n\nA. Begin oral amoxicillin-clavulanate immediately for $10$ days to prevent suppuration; advise return only if airway compromise develops.\n\nB. Do not start antibiotics now; explain likely reactive viral lymphadenopathy and provide safety-net instructions to return urgently for fever $\\ge 38.5^\\circ\\text{C}$, rapid node enlargement or size $\\ge 2$ cm, increasing tenderness, overlying erythema or warmth, fluctuance, limited neck motion, trismus, dysphagia, drooling, respiratory distress, systemic toxicity, or persistence beyond $4$–$6$ weeks or failure to improve within $2$ weeks; arrange follow-up in $1$–$2$ weeks.\n\nC. Start a short course of systemic corticosteroids to hasten resolution; antibiotics are unnecessary and follow-up is not required unless nodes persist beyond $12$ weeks.\n\nD. Order immediate contrast-enhanced computed tomography (CT; computed tomography) of the neck and start intravenous clindamycin due to risk of deep neck space infection despite afebrile status and normal laboratory values.\n\nE. Provide reassurance with no antibiotics and no explicit safety-net instructions; schedule routine annual follow-up only.",
            "solution": "The clinical presentation is classic for reactive viral lymphadenopathy. The patient is well-appearing and afebrile, with bilateral, small, non-tender lymph nodes in the context of a mild upper respiratory infection. Furthermore, the laboratory data, including a normal white blood cell count and low inflammatory markers (CRP and ESR), strongly argue against a significant bacterial infection. In this scenario, antibiotics are not indicated, and the core principles of management are antibiotic stewardship, parental education, and ensuring a safe plan for follow-up and monitoring.\n\n*   **Option A** is incorrect because antibiotics are not needed for a presumed viral process and the safety-net advice is dangerously insufficient, only mentioning a late, severe complication.\n*   **Option B** is the correct choice. It correctly defers antibiotics, provides an excellent rationale (likely viral cause), and offers comprehensive, specific safety-net instructions. These instructions cover the key signs of a potential bacterial superinfection, deep neck space infection, or an unusual disease course. It also includes appropriate follow-up to ensure resolution, which is a critical safety component of \"watchful waiting.\"\n*   **Option C** is incorrect because corticosteroids have no role in simple reactive lymphadenopathy and could mask worsening symptoms. The follow-up interval is also inappropriately long.\n*   **Option D** represents significant and unnecessary over-investigation and overtreatment. A CT scan and intravenous antibiotics are not warranted in a well-appearing, afebrile child with no signs of a complicated infection.\n*   **Option E** is incorrect because, while it correctly withholds antibiotics, it fails to provide any explicit safety-net instructions, which is a critical omission and considered substandard care.\n\nTherefore, option B provides the most appropriate, comprehensive, and safe management plan.",
            "answer": "$$\\boxed{B}$$"
        },
        {
            "introduction": "When the clinical presentation strongly suggests acute bacterial lymphadenitis, the focus shifts from observation to decisive action. This practice  challenges you to synthesize your knowledge of likely pathogens, appropriate empiric antibiotic selection, and the role of diagnostic imaging. Your task is to construct a complete and safe initial outpatient management plan for a child with a presumed pyogenic infection.",
            "id": "5114765",
            "problem": "A parent brings a previously healthy, fully immunized $4$-year-old child with $2$ days of fever to $39^{\\circ}\\mathrm{C}$, irritability, and a unilateral tender anterior cervical lymph node measuring approximately $3$ cm with overlying erythema. There is no drooling, no trismus, and the child tolerates oral intake. Oropharyngeal examination shows mild pharyngeal erythema without exudates. Lungs are clear, there is no stridor, and there are no dental caries or periodontal disease on inspection. The child is nontoxic and hemodynamically stable. Using core definitions of acute bacterial cervical lymphadenitis in children and well-tested clinical facts about pathogen epidemiology, imaging modality selection, antimicrobial pharmacology, and indications for procedural intervention, select the single most appropriate initial, comprehensive outpatient management plan that addresses diagnostics, empiric antimicrobial coverage, and follow-up (assume no known drug allergies and unknown local prevalence of Methicillin-Resistant Staphylococcus aureus (MRSA)).\n\nA. Order point-of-care ultrasonography of the neck to assess for suppuration; begin oral clindamycin at $10$ mg/kg/dose every $8$ hours (maximum $450$ mg/dose) for $10$ days to cover MRSA and Group A Streptococcus (GAS); provide strict return precautions and schedule reassessment in $24$–$48$ hours; if an abscess is identified or clinical deterioration occurs, arrange needle aspiration or surgical drainage and consider intravenous (IV) therapy; avoid computed tomography (CT) unless deep neck space infection is suspected.\n\nB. Obtain urgent contrast-enhanced CT of the neck to delineate anatomy and admit for broad-spectrum IV vancomycin plus piperacillin-tazobactam; consult Ear, Nose, and Throat (ENT) for immediate incision and drainage regardless of imaging results.\n\nC. Start oral amoxicillin at $45$ mg/kg/day in two divided doses for $5$ days without imaging and plan follow-up in $7$ days; add a short course of systemic corticosteroids to hasten resolution; obtain blood cultures.\n\nD. Begin azithromycin to target Bartonella henselae and order an interferon-gamma release assay (IGRA); schedule excisional lymph node biopsy in $48$ hours if no improvement; defer imaging unless airway symptoms develop.\n\nE. Defer imaging; start oral cephalexin at $50$ mg/kg/day divided every $6$ hours for $10$ days to cover methicillin-susceptible Staphylococcus aureus (MSSA) and GAS; arrange follow-up in $72$ hours; consider CT if there is no improvement after $1$ week.",
            "solution": "The clinical presentation—acute onset of fever with a unilateral, tender, erythematous lymph node—is characteristic of acute bacterial lymphadenitis. The most common pathogens are *Staphylococcus aureus* and *Streptococcus pyogenes* (GAS). Since the child is stable and can be managed as an outpatient, the plan must include appropriate imaging, empiric antibiotics, and close follow-up.\n\n*   **Imaging**: Ultrasound is the ideal initial imaging modality to differentiate between phlegmon (inflammation without a drainable fluid collection) and an abscess. It is radiation-free and highly effective.\n*   **Antibiotics**: Because the local prevalence of Methicillin-Resistant *S. aureus* (MRSA) is unknown, it is prudent to choose an empiric antibiotic that covers both GAS and MRSA. Clindamycin is an excellent choice for this.\n*   **Follow-up**: Close follow-up within 24-48 hours is essential to assess the response to treatment.\n\nAnalyzing the options:\n*   **Option A** is the most comprehensive and correct plan. It correctly chooses ultrasound for imaging, clindamycin for robust empiric coverage (including MRSA), and sets a safe, close follow-up interval. It also provides a clear contingency plan for escalation of care if needed.\n*   **Option B** represents significant overtreatment. Admission, IV antibiotics, and a CT scan are not indicated for a stable outpatient. I&D without confirmation of an abscess is incorrect.\n*   **Option C** is incorrect because amoxicillin provides poor coverage for *S. aureus*, the follow-up interval is too long, and corticosteroids are not indicated.\n*   **Option D** incorrectly focuses on atypical pathogens (*Bartonella*, TB) which do not fit this acute, pyogenic presentation.\n*   **Option E** is a reasonable alternative but is less optimal than A. Cephalexin does not cover MRSA, which is a risk given the unknown prevalence. The 72-hour follow-up is acceptable but less cautious than 24-48 hours.\n\nTherefore, option A represents the best practice by providing robust antibiotic coverage in the face of uncertainty, using the most appropriate imaging, and ensuring a safe and timely follow-up plan.",
            "answer": "$$\\boxed{A}$$"
        },
        {
            "introduction": "While the majority of cervical lymphadenitis cases are infectious and self-limited, a clinician's vigilance for signs of serious underlying disease is paramount. This final exercise  presents a scenario with multiple \"red flag\" features concerning for malignancy. It tests your ability to recognize these warning signs, understand their implications, and justify the necessary and definitive step of proceeding with a tissue biopsy.",
            "id": "5114748",
            "problem": "A $12$-year-old previously healthy boy presents with left posterior cervical lymph node enlargement persisting for $8$ weeks. The largest node measures approximately $3.2$ cm on ultrasonography, is hard and immobile on palpation, non-tender, and not overlying any erythema or warmth. He reports drenching night sweats occurring several nights per week and unintentional weight loss of approximately $2.5$ kg over the same period. He completed a $10$-day course of amoxicillin-clavulanate $4$ weeks ago without any change in node size. There is no recent pharyngitis, dental infection, or known cat exposure. He denies recent travel. On examination, he has mild pallor and a palpable splenic tip; there is no airway compromise or fluctuant mass.\n\nLaboratory data include Complete Blood Count (CBC) with hemoglobin $10.8$ g/dL, white blood cell count $6.5 \\times 10^{9}$/L, platelets $270 \\times 10^{9}$/L; Erythrocyte Sedimentation Rate (ESR) $48$ mm/hour; C-Reactive Protein (CRP) $9$ mg/L; Lactate Dehydrogenase (LDH) $420$ U/L. Epstein-Barr Virus (EBV) viral capsid antigen immunoglobulin M is negative; cytomegalovirus immunoglobulin M is negative. Tuberculin skin testing with purified protein derivative (PPD) is $0$ mm at $48$ hours. Chest radiograph shows no mediastinal widening. Neck ultrasonography demonstrates a rounded, hypoechoic node with absent fatty hilum and predominantly peripheral vascularity.\n\nStarting from core definitions of cervical lymphadenitis as inflammatory enlargement of lymph nodes, the expected time course for resolution of uncomplicated reactive nodes, and well-established red flag features that suggest malignant or atypical etiologies (hard consistency, fixation to surrounding tissues, constitutional “B” symptoms, supraclavicular location, abnormal architecture on imaging, and persistence beyond $6$ weeks), which of the following is the single most appropriate next step in management for this patient?\n\nA. Watchful waiting for an additional $2$ weeks with reassurance and no further testing\n\nB. Initiate clindamycin to target Staphylococcus aureus and group A Streptococcus with re-evaluation in $72$ hours\n\nC. Perform ultrasonography-guided Fine-Needle Aspiration (FNA) for cytology and culture to avoid general anesthesia\n\nD. Proceed to excisional biopsy of the most abnormal node for comprehensive histopathology, mycobacterial and fungal stains, and flow cytometry, while avoiding corticosteroids until a tissue diagnosis is obtained\n\nE. Begin an empirical prednisone taper to reduce nodal size and schedule outpatient oncology follow-up within $2$ weeks",
            "solution": "This patient's presentation has numerous \"red flag\" features highly suspicious for malignancy, most likely lymphoma. These features include:\n*   **Chronicity and Treatment Failure**: The node has persisted for 8 weeks and did not respond to antibiotics.\n*   **Physical Characteristics**: The node is large ($3.2$ cm), hard, immobile (fixed), and non-tender.\n*   **Systemic \"B\" Symptoms**: The presence of drenching night sweats and unintentional weight loss.\n*   **Other Clinical Signs**: Splenomegaly (palpable splenic tip) and anemia suggest a systemic disease.\n*   **Laboratory Findings**: Elevated LDH (a marker of high cell turnover) and ESR.\n*   **Imaging**: Ultrasound findings (rounded node, absent fatty hilum, peripheral vascularity) are all classic for malignancy.\n\nGiven this overwhelming evidence, the primary goal is to obtain a definitive tissue diagnosis.\n*   **Option A (Watchful waiting)** and **Option B (Antibiotics)** are incorrect and unsafe as they would delay the diagnosis of a likely malignancy.\n*   **Option C (Fine-Needle Aspiration)** is suboptimal for a primary diagnosis of lymphoma. FNA provides cells but not tissue architecture, which is crucial for accurate classification of lymphomas. An inconclusive FNA would only lead to further delays.\n*   **Option E (Empirical Prednisone)** is dangerous and strongly contraindicated. Corticosteroids can cause cancer cells to die off (lysis), which may make a subsequent biopsy non-diagnostic. This could severely compromise the ability to correctly identify the type of cancer and plan treatment.\n*   **Option D** represents the gold standard of care. An excisional biopsy provides the entire node, allowing for comprehensive analysis of its architecture (histopathology) and for ancillary studies like flow cytometry (to identify cell types) and special stains (to rule out infection). Avoiding corticosteroids before the biopsy is a critical safety measure to ensure an accurate diagnosis.",
            "answer": "$$\\boxed{D}$$"
        }
    ]
}